Compare SAR & MOBI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | SAR | MOBI |
|---|---|---|
| Founded | 2007 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Investment Managers | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 362.9M | 383.0M |
| IPO Year | 2006 | 2026 |
| Metric | SAR | MOBI |
|---|---|---|
| Price | $18.27 | $11.39 |
| Analyst Decision | Hold | |
| Analyst Count | 4 | 0 |
| Target Price | ★ $23.75 | N/A |
| AVG Volume (30 Days) | ★ 118.9K | 109.1K |
| Earning Date | 05-05-2026 | N/A |
| Dividend Yield | ★ 14.34% | N/A |
| EPS Growth | ★ 14.36 | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $0.39 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $17.34 | $10.34 |
| 52 Week High | $25.64 | $15.19 |
| Indicator | SAR | MOBI |
|---|---|---|
| Relative Strength Index (RSI) | 36.71 | 47.04 |
| Support Level | $17.34 | $10.67 |
| Resistance Level | $23.69 | $11.61 |
| Average True Range (ATR) | 0.37 | 1.05 |
| MACD | -0.02 | -0.02 |
| Stochastic Oscillator | 14.71 | 26.21 |
Saratoga Investment Corp is a specialty finance company that provides customized financing solutions to U.S. middle-market businesses. The company invests in senior and unitranche leveraged loans and mezzanine debt, and, to a lesser extent, equity to provide financing for change of ownership transactions, strategic acquisitions, recapitalizations and growth initiatives in partnership with business owners, management teams and financial sponsors. Its objective is to create attractive risk-adjusted returns by generating current income and long-term capital appreciation from its debt and equity investments.
Mobia Medical Inc is a commercial-stage medical device company redefining stroke recovery for survivors living with life-altering motor impairments. The company develops, markets and sells devices for the treatment of medical conditions. Its flagship device is the Vivistim Paired Vagus Nerve Stimulation system, which is used to support motor function rehabilitation in patients with chronic ischemic stroke. The company generates all of its revenue from the sale of the Vivistim System to customers, mainly primary and comprehensive stroke centers, in the United States.